YAP1 and cholangiocarcinoma: To compare the expression levels of YAP1 signaling pathway genes between tumor and normal tissue samples, we used the TIMER2.0 platform to evaluate the expression profiles based on the cholangiocarcinoma cohort (CHOL) obtained from TCGA (The Cancer Genome Atlas) database [27].